Public Relations

Media Mind surveys best to work for

Media Mind just completed its annual survey of healthcare journalists, tallying their thoughts and views on pharmaceutical companies, insurers, agencies, and medical centers.

MS&L appoints Peter Harris, Renee Wilson as new directors

By

MS&L has appointed Peter Harris to director of its corporate practice in North America, and Renee Wilson to managing director of its New York office.

PR View by Susan Isenberg

In today's trust-bereft marketplace, it's engagement that people crave, and engagement that builds trust.

Porter Novelli hires president, CFO

By

Porter Novelli has hired Anthony Viceroy as president of global business operations and chief financial officer. Viceroy will report to Gary Stockman, the agency's CEO.

WeissComm acquires ODA, expands offerings

By

WeissComm has announced the acquisition of ODA, a San Francisco-based creative shop focused on healthcare brands.

PR View by Paul Oestreicher, PhD

CNN's sacking some of its most experienced science journalists and producers could not come at a worse time.

Sanofi partnering with Maryland community

By

Sanofi-Aventis launched a community health partnership in Baltimore, in response to disturbing health trends among African-Americans there.

New PR shop to offer nimble alternatives

By

Hoping to address PR needs in light of shrinking budgets, Shannon Troughton has launched VoxPop Public Relations, in Indianapolis.

PR View by Laura Schoen

Signs of wrenching change for the industry were unmistakable even before the economic crisis.

Porter Novelli ponders life and death

By

During a period of economic instability, consumers tend to focus on day-to-day life, rather than considering the long view.

Covidien launches site on bariatric's benefits

By

Medical device and surgical manufacturer Covidien has launched a website to educate patients and physicians on the benefits of bariatric surgery as a treatment for Type 2 diabetes.

PR View by Tom Jones

Nearly five years after the human genome was decoded, the age of genetics is finally upon us; "personalized medicine" has arrived.

Porter Novelli partnering with CMS

By

Porter Novelli's Washington, DC, office landed a multimillion dollar contract from the Centers for Medicare and Medicaid Services (CMS).

Johnson & Johnson reorganizes its PR team

By

Johnson & Johnson (J&J) has announced a restructuring of its public affairs and corporate communications team.

PR View by Maryellen Royle

As a company that focuses on healthcare PR, we are often involved in early-stage product communications.

Senetek PLC taps Michael Rogers PR

By

Senetek PLC, a life sciences company focused on anti-aging technologies, has tapped Michael Rogers PR for the launch of its Pyratine-6 product.

Fleishman-Hillard wins Siemens assignment

By

Fleishman-Hillard has won an AOR assignment for Siemens Medical System's AG's global health division.

PR View by Diane Weiser

This year has not been kind to biopharmaceutical companies.

Bayer, Jonas bro urging diabetes care

By

Bayer Diabetes Care has partnered with Nick Jonas for a campaign urging young people to proactively manage diabetes.

Xperience Comms: 'Think of doctors as consumers'

By

Joseph Wenke, partner and creative director at Xperience Communications, says bringing marketing principles into discussions with doctors makes sense.

PR View by Rob Rogers

Let's be clear. As one who has spent half a life working in the increasingly regulated "pay for what you get" advertising side of the communication business, I have regarded PR as something of an uncertain universe.

CCC unveils new compliance portal

By

Responding to the billions of dollars in industry fines paid under the False Claims Act, the Center for Communication Compliance (CCC) launched a new online compliance portal.

Cohn & Wolfe launches global firm: GCI Health

By

Cohn & Wolfe has launched GCI Health, a global public relations firm.

PR View by Helene Ellison

When pharmaceutical companies choose to maintain a favorable and high-profile media presence, the benefits are commercially advantageous, with measurable corporate, investor and marketing and sales impact.

Role of influencers varies among consumers

By

In a study conducted by public relations agency Ketchum, researchers uncovered a variety of factors that pinpoint the way consumers make decisions about healthcare.

WellPoint taps Ricochet PR as AOR

By

WellPoint, a national health benefits provider, named Ricochet Public Relations as its first agency of record. Duties

PR View by Sally Barton

Whenever the subject of healthcare and new media comes up, the refrain is almost always: "we're way behind."

SEO PR helps level online playing field

By

Websites aren't the only thing to consider when employing search engine optimization (SEO), according to PR practitioners and service providers.

Burson-Marsteller names Cohen new global chair

By

Burson-Marsteller has appointed Gail Cohen to global chair of the firm's healthcare practice.

PR View by Charlotte Wray

The question of public relations versus other marketing spends is probably a debate that never will go quietly into the night.

Study looks at cholesterol Rx publicity

By

Voluminous press coverage over cholesterol drug safety have led to a study measuring consumer perception.

WeissComm promotes Weiser to president, COO

By

WeissComm Partners has promoted Diane Weiser to the position of president and chief operating officer.

PR View by Craig Fuller

The conventional wisdom is that uncertainty about the 2008 elections makes healthcare strategic planning difficult. Or, maybe not.

PhRMA strikes a more conciliatory note

By

DTC ads can be "both a blessing and a curse," and if companies fail to include messaging about patient assistance programs in them, "then your message is a resentful one."

Centocor joins its parent company in blogosphere

By

Centocor launched itself into the blogosphere with the debut of its corporate blog at cnto411.com.

PR View by Ann Moravick

Go online and you'll see bountiful commentary about drug companies and their products.

Lilly slams Times over trials data charge

By

Lilly took a sharp tone in responding to a New York Times article that the company said "likely created a strong false impression with readers that Lilly suppresses data."

Wyeth taps Cost to head corporate affairs dept.

By

Wyeth hired Timothy Cost to head its corporate affairs department, replacing Marily Rhudy, who is retiring.

PR View by Michael Boken

When choosing a celebrity product spokesperson in the scrutinized world of pharmaceutical communications, it's essential that great care and consideration is put into the selection.

PR View by Paul Oestreicher

It's a reflection of our times: if you're in healthcare you must also have political smarts.

Merck, Pfizer look outside industry for PR execs

By

Two top pharmas looked outside the industry for their top communications executives

Patient groups prompt NYU to pull ads

By

Bowing to outraged patient advocates, NYU Child Study Center said it will halt its controversial print and outdoor ads aimed at raising awareness of mental health problems in kids.

PR View by Lynn Hanessian

The consumer has arrived in health.

PhRMA PPA spokesman snaps, scores bad press

By

Montel Williams, the talk-show host and spokesman for PhRMA's Partnership for Prescription Assistance, generated some unwelcome publicity when he lashed out at a 17-year-old intern from a Savannah, GA, newspaper at a November event for the patient assistance program.

Wadler to head MWW health offering

By

MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.

PR View by Gil Bashe

Treating rare disorders was once considered a "good-will science endeavor," but market forces have encouraged companies to revisit how these small molecules can be big business, and researchers are finding that therapeutic applications for one rare disease area often holds promise in others.

Pfizer pfudges with its withdrawal of Exubera

By

Pfizer and Nektar have buried the hatchet after the former paid the latter $135 million following its abrupt decision to discontinue marketing of Exubera, on which the two firms partnered.

Novartis targets oncologists with blog

By

Novartis is experimenting with blogging for physicians with melanomaperspectives.com.

PR View by Lynn Hanessian

Keeping up with new communication technologies and online trends is a critical bar for entry in our business.

Sanofi corrals stars for cancer awareness effort

By

Sanofi-Aventis is partnering with four major cancer patient groups and Wachovia to produce a star-studded series of events aimed at raising awareness of women's cancers.

Email Newsletters